An Innovative Pipeline

Advancing a promising adjuvant therapy for a broad range of treatment-resistant cancers.

Research Summary

Program

DISCOVERY

PRE-CLINICAL

CLINICAL

PATIENT BASE*

Glioblastoma

Your Content Goes Here

30,000¹

Breast Cancer

Your Content Goes Here

4 million²

Colon Cancer

Your Content Goes Here

1.4 million³

Melanoma

Your Content Goes Here

1.3 million⁴

Pancreatic Cancer

Your Content Goes Here

60,000⁵

Lung Cancer

Your Content Goes Here

600,000⁶

*Estimated numbers of people living with each type of cancer in the United States.
¹ National Brain Tumor Society. ² BreastCancer.org. ³ American Cancer Society Journals. ⁴ National Cancer Institute. ⁵ National Cancer Institute. ⁶ National Cancer Institute.

Our Research Pipeline

Studying JM2’s novel effects in multiple cancer models.

Preparing for clinical trials.

Preparing for clinical trials.

Pre-clinical research in progress.

Under research and development.

Under research and development.

Under research and development.

Glioblastoma

Breast Cancer

Colon Cancer

Lung Cancer

Pancreatic Cancer

Melanoma

Want to learn more about our research?